Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery

NCT07486570
completed

Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon

NCT04340856
completed

Mortality Score in Elderly Patients With Colon Cancer

NCT04538404
completed

Predictive Value of Procalcitonin, CRP, Drain Fluid Culture, Il-6 and Tnf-α in Anastomotic Leakage

NCT02361918

Clinical Trials (4)

Showing 4 of 4 trials
NCT07486570Not Applicable

Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery

Recruiting
NCT04340856

Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon

Completed
NCT04538404

Mortality Score in Elderly Patients With Colon Cancer

Completed
NCT02361918

Predictive Value of Procalcitonin, CRP, Drain Fluid Culture, Il-6 and Tnf-α in Anastomotic Leakage

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4